← Leaderboards
Christian Ludwig Roth
Seattle Children'S Hospital
$8,363,703
Attributed
$10,886,983
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,886,983 · 6
By mechanism
R01$10,076,943 · 4
R21$531,174 · 1
R41$278,866 · 1
Top collaborators
- M. Jennifer Abuzzahab4 shared
- Robert P Doyle4 shared
- Shana Erin Mccormack2 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- M. Jennifer Abuzzahab$913,167
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityBody Weight DecreasedResponseSuccessBrainObesity TreatmentChildEatingPharmaceutical PreparationsAgonistTreatment ResponseGlp-I ReceptorHypothalamic StructureAdultResistanceDesire For FoodInsightLeadSatiationBrain RegionBaseFamilyNeuroimagingArea
Grant awards (20)
Development of Anorexigenic and Glucoregulatory Chimeric Peptides$674,227
R01 · FY2025 · DK · contact PI
Development of Anorexigenic and Glucoregulatory Chimeric Peptides$644,494
R01 · FY2024 · DK · contact PI
Efficacy of Novel Melanocortin and Gut-peptide Dual Agonists for Childhood Obesity Treatment$531,174
R21 · FY2024 · HD · contact PI
Phentermine/Topiramate in children, adolescents, and young adults with hypothalamic obesity: a pilot and feasibility study$328,635
R01 · FY2024 · DK · contact PI
Development of Anorexigenic and Glucoregulatory Chimeric Peptides$680,023
R01 · FY2023 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$656,880
R01 · FY2023 · DK · contact PI
Phentermine/Topiramate in children, adolescents, and young adults with hypothalamic obesity: a pilot and feasibility study$361,675
R01 · FY2023 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$660,035
R01 · FY2022 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$670,979
R01 · FY2021 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$680,326
R01 · FY2020 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$701,841
R01 · FY2019 · DK · contact PI
Novel, Potent and Metabolically Stable Oxytocin Analogues to Treat Obesity$278,866
R41 · FY2019 · DK · contact PI
Glucagon-like peptide-1 agonist effects on energy balance in hypothalamic obesity$296,126
R01 · FY2018 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$515,923
R01 · FY2017 · DK · contact PI
Glucagon-like peptide-1 agonist effects on energy balance in hypothalamic obesity$491,489
R01 · FY2017 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$593,096
R01 · FY2016 · DK · contact PI
Glucagon-like peptide-1 agonist effects on energy balance in hypothalamic obesity$489,637
R01 · FY2016 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$553,118
R01 · FY2015 · DK · contact PI
Glucagon-like peptide-1 agonist effects on energy balance in hypothalamic obesity$549,081
R01 · FY2015 · DK · contact PI
Brain systems and behaviors underlying response to obesity treatment in children$529,358
R01 · FY2014 · DK · contact PI